SCHEMBL2628083

SCHEMBL2628083

Cc1onc(-c2ccc(F)cc2)c1/C=C/c1cc(C(=O)N2CCS(=O)(=O)CC2)[nH]n1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 10/20 0.49
GABRA1 P14867 2/20 0.49
GABRG2 P18507 2/20 0.49
GABRB3 P28472 2/20 0.49
GABRA3 P34903 1/20 0.49
GABRA2 P47869 1/20 0.49
KDM4E B2RXH2 1/20 0.39
TACR3 P29371 1/20 0.38
KCNH2 Q12809 1/20 0.37
USP2 O75604 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
HTT P42858 2/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL285751 1.00 GABRA5 (0.49) GABRA5GABRA1GABRG2GABRB3GABRA3
SCHEMBL286295 0.89 GABRA5 (0.47) GABRA5GABRG2GABRB3KDM4ETACR3
SCHEMBL286296 0.89 GABRA5 (0.47) GABRA5GABRG2GABRB3KDM4ETACR3
SCHEMBL286240 0.83 GABRA5 (0.40) GABRA5GABRA1GABRG2GABRB3GABRA3
SCHEMBL286239 0.83 GABRA5 (0.40) GABRA5GABRA1GABRG2GABRB3GABRA3
SCHEMBL286679 0.82 GABRA5 (0.49) GABRA5GABRA1GABRG2GABRB3GABRA3
SCHEMBL2628082 0.82 GABRA5 (0.49) GABRA5GABRA1GABRG2GABRB3GABRA3
SCHEMBL286110 0.82 ALPL (0.48) GABRA5KDM4EKMT2AMAPK1
SCHEMBL285881 0.82 KDM4E (0.43) GABRA5KDM4ENPC1RAB9ATP53
SCHEMBL286109 0.82 ALPL (0.48) GABRA5KDM4EKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163728-B2 Pyrazoles HOFFMANN-LA ROCHE INC. (US) 2012-04-24 US disclosed
US-8163728-B2 Pyrazoles HOFFMANN-LA ROCHE INC. (US) 2012-04-24 US disclosed
WO-2010127975-A1 ISOXAZOLE-PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2010-11-11 WO disclosed
US-20100286115-A1 PYRAZOLES ROCHE PALO ALTO LLC 2010-11-11 US disclosed
US-20100286115-A1 PYRAZOLES ROCHE PALO ALTO LLC 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286115-A1 PYRAZOLES GABRA5, GABRA1, GABRA3 GABRA5 1/4885GABRA1 2/4885GABRG2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.